Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DCL000900

Drug Information
NameNS 2359    
CompanyGlaxoSmithKline    
IndicationAttention-deficit/hyperactivity disorder, depression and cocaine addictionDiscontinued in 2009 in phase II    [1]
CAS NumberCAS 843660-54-8
ClinicalTrials.govNCT00467428;    
TargetSerotonin reuptakeMultitarget[2]
Dopamine reuptakeInhibitor[2]
Dopamine reuptakeMultitarget[2]
Norepinephrine reuptakeInhibitor[2]
Norepinephrine reuptakeMultitarget[2]
Serotonin reuptakeInhibitor[2]
Ref 1Novel drugs and therapeutic targets for severe mood disorders. Neuropsychopharmacology. 2008 Aug;33(9):2080-92. Epub 2008 Jan 2. To Reference
Ref 2Emerging drugs for attention-deficit/hyperactivity disorder. Expert Opin Emerg Drugs. 2007 Sep;12(3):423-34. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543